To demonstrate the functional consequence of glaucine in metastatic breast cancer, we used it to treat MDA-MB-231 cells, a highly metastatic breast cancer cell line that highly expresses MMP-9 and constitutively activated NF-κB [21, 22]. This evidence concerns the gene NFKB1 and breast carcinoma.